Tracking a retatrutide schedule

By Tessaro Pty Ltd, the maker of Pepti · Reviewed

This page is about the record, not the regimen. It explains why retatrutide tracking tends to follow a weekly pattern and what a good log captures. It does not contain a dose, a titration amount, or a schedule for you to follow.

What retatrutide is

Retatrutide is an investigational triple agonist, acting on the GIP, GLP-1 and glucagon receptors. It is in Phase 3 clinical trials and is not approved by any regulator for any use. Because it is unapproved, there is no label, no authorised dosing, and no clinician-facing guidance for it outside of trial protocols. Anything you have read about what it does or how well it works comes from trial reporting, not from an approved indication, and this page makes no claim either way.

Why the tracking follows a weekly pattern

Structurally, people who log retatrutide log it on a weekly cadence: one entry per week, on the same day, stepping up over time in stages set by whoever directs their use. That shape comes from the trial design and is the reason a log for it looks different from a daily-injection log. Two things follow from it. First, a missed week is a bigger gap than a missed day, so the record needs to make a missed week obvious at a glance. Second, each titration step is a change in what you are doing, and the date of that change is the single most useful fact in the whole history when you look back. To be plain: this page provides no doses and no titration amounts. The figures belong to you and the person directing your use, and the log exists to record what those were, when.

What matters in tracking it

The record is the point

With a weekly compound, there are relatively few entries, which makes each one matter more. A clean log of day, time, site, vial, weight and any change in step gives you and whoever directs your use something real to look at. The general method is in how to track peptide cycles properly; the reconstitution working is in the reconstitution guide.

This page describes record-keeping only. It does not recommend retatrutide or any other substance, and it provides no dose, titration amount, or schedule. Retatrutide is investigational and not approved for any use.

Pepti’s peptide tracker app keeps the weekly log, the site sequence, the vial count and the weight trend in one place.

Not medical advice. Pepti is a record-keeping and measurement tool, not a medical device.

Get Pepti on the App Store